Skip to content

The Effects of Acanthopanax senticosus on Anxiety, Motivation to Learn, Sleep Status, and Fatigue Associated with Learning Status in Students

The Effects of Acanthopanax senticosus on Anxiety, Motivation to Learn, Sleep Status, and Fatigue Associated with Learning Status in Students - The Effects of Acanthopanax senticosus on Anxiety, Motivation to Learn, Sleep Status, and Fatigue Associated with Learning Status in Students

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000052295
Enrollment
20
Registered
2023-09-25
Start date
2023-10-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

male/female adults

Interventions

Sponsors

Suzuka University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Healty Subjects. 2.Subjects who are males or females and are aged 18 or older. 3.Subjects who have provided written consent for participation in the study.

Exclusion criteria

Exclusion criteria: 1.The persons who have taken Acanthopanax Senticosus and are not off it for more than 3 months. 2.Those who regularly use health foods that may affect the study. 3.Allergy to Acanthopanax Senticosus. 4.Subject who is not currently receiving treatment or medication. 5.Subject with current or history of alcohol dependence. 6.Those who are participating in other clinical studies. 7.Subject with severe diseases such as hepatic disorder, kidney disorder, heart disease. 8.Subject who have hepatitis. 9.Severe anemia. 10.Subjects with systolic blood pressure more than 180 mmHg or diastolic blood pressure more than 90 mmHg. 11.Other cases that the principal investigator and subinvestigators deem inappropriate as research subjects.

Design outcomes

Primary

MeasureTime frame
1.Questionnaires for subjective 2.General Self-efficacy Scale (GSES) 3.OSA sleep inventory 4.STAI

Secondary

MeasureTime frame
1.salivary amylase 2.salivary cortisol 3.Autonomic activity 4.Objective sleep quality (measured using actigrapgh)

Countries

Japan

Contacts

Public ContactFujishima Masaki

Sun Chlorella Corp. Production & Development Department Research & Development Group

mfujishima@sunchlorella.co.jp075-288-3010

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026